Guatemala Vital Statistics 2021
Vital registration:
Subnationally representative
COVID-19
Dataset Records for COVID-19
Displaying 201 - 250 of 1633
Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022
GHDx Entry last modified on: Mar 22, 2024
Analysis of Post-COVID-19 Guillain-Barré Syndrome over a Period of One Year in the University Hospital of Split (Croatia)
GHDx Entry last modified on: Oct 23, 2024
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study)
GHDx Entry last modified on: Jan 31, 2024
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India. Preprint
GHDx Entry last modified on: May 12, 2022
A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021
GHDx Entry last modified on: Mar 14, 2022
Russia Natural Movement of the Population 2022
Естественное Движение Населения В Разрезе Субъектов Российской Федерации За 2022 Года
Vital registration:
Subnationally representative
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia
GHDx Entry last modified on: Jan 31, 2024
The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq
GHDx Entry last modified on: Mar 22, 2024
Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France
GHDx Entry last modified on: Nov 11, 2024
Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
GHDx Entry last modified on: Apr 10, 2023
Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal
GHDx Entry last modified on: Mar 22, 2024
United States COVID Tracking Project 2021
The COVID Tracking Project at The Atlantic
Canada - Ontario Daily Epidemiological Summary of COVID-19 2021
Epidemiologic Summary COVID-19 in Ontario
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
GHDx Entry last modified on: Jan 31, 2024
El Salvador Global Youth Tobacco Survey 2021
Survey:
Cross-sectional - Facility (non-health) - Individual - Nationally representative
Seychelles Annual Health Sector Report 2021
Report:
Nationally representative
Japan Provisional Cases of Notifiable Diseases by Prefecture 2021
IDWR Surveillance Data Table 2021: Notifiable Diseases
Epi surveillance:
Subnationally representative
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic
GHDx Entry last modified on: Apr 10, 2023
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.1.7 2021
GHDx Entry last modified on: Jun 14, 2023
IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021. Preprint
GHDx Entry last modified on: Apr 8, 2022
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
GHDx Entry last modified on: Apr 10, 2023
Three-month Clinical Status of A Cohort of Adult Hospitalized COVID-19 Pimpaka Srisiriwanna M.D., Poolsuk Janepanish Visudtibhan Ph.D., Kumthorn Malathum M.D
GHDx Entry last modified on: Mar 22, 2024
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
GHDx Entry last modified on: Mar 22, 2024
Italy Open Data on COVID-19 Vaccines 2020-2022
covid19-opendata-vaccini, Open Data su consegna e somministrazione dei vaccini anti COVID-19 in Italia
Long COVID in South Africa: Findings from a Longitudinal Cohort of Patients at One Month after Hospitalisation with SARS-COV-2, Using an Isaric Multi-Country Protocol
Survey:
Epi surveillance - Individual - Interview - Longitudinal - Subnationally representative
United States - COVID-19 Reported Patient Impact and Hospital Capacity by State Timeseries 2020-2022
Epi surveillance:
Health facility - Subnationally representative
United States - COVID-19 Reported Patient Impact and Hospital Capacity by Facility 2020-2022
COVID-19 Reported Patient Impact and Hospital Capacity by Facility
Epi surveillance:
Health facility
COVID-19 Vaccination and Case Trends by Age Group, United States 2020-2022
Archive: COVID-19 Vaccination and Case Trends by Age Group, United States
Administrative data:
Epi surveillance
Unemployment Insurance (UI) Benefits: Permanent-Law Programs and the COVID-19 Pandemic Response
Report:
Financial - Nationally representative
Covid-19 Vaccination Strategy In Spain 2020-2022
Estrategia De Vacunación Covid-19 En Espana
Niger Performance Monitoring and Action Phase 1 Household and Female Survey 2020-2021
Niger Phase 1 HQFQ Survey / PMA Niger Phase 1 Household and Female Survey Dataset, Version 1.0
Survey:
Cross-sectional - Household - Individual - Interview - Longitudinal - Nationally representative - Urban-rural representative
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2020-2021 - Round 2
GHDx Entry last modified on: Aug 4, 2023
Colombia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
Democratic Republic of the Congo Kinshasa and Kongo Central Performance Monitoring and Action Phase 2 Household and Female Survey 2020-2021
DRC Phase 2 (Kinshasa; Kongo Central) HQFQ Survey
Survey:
Cross-sectional - Household - Individual - Interview - Longitudinal
Malawi COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Australia Household Impacts of Covid-19 Survey November 2020
Survey:
Longitudinal
Canada - British Columbia COVID-19 Situation Report 2020-2022
British Columbia (BC) COVID-19 Situation Report
Subscribe